MSB had good reason to mention the term collegiate. The levels that they were dealing with regularly were exactly that.
But higher up the echelons, and across different responsibilities in the FDA, people had their own axe to grind.
These are the perils of dealing with an organisation that got progressively less accountable and rigorous under the Trump regime.
Conflict of interest means nothing to Trump.
Ann: Mesoblast Type A Meeting with FDA, page-449
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.40 |
Change
0.025(1.82%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.41 | $1.38 | $1.590M | 1.138M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 8569 | $1.40 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.40 | 8529 | 6 |
View Market Depth
| Last trade - 12.04pm 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |